EBITDA
868% Increase in Software Adjusted EBITDA, Strengthened Balance Sheet, Growing Software Revenues and Client Numbers, While Gross Margin Grows for Third Consecutive Quarter Other OTC:HLIX
DENVER, CO, Nov. 13, 2020 (GLOBE NEWSWIRE) — via NewMediaWire ‒ Helix Technologies, Inc. (OTCQB:HLIX) (the “Company”) today reported its results for the third quarter of 2020, continuing with strong growth in its core software business and maintaining positive adjusted EBITDA despite increased one-time merger related expenses. Helix again delivered strong revenue numbers with increasing year-over-year …
Emerald Health Therapeutics’ Pure Sunfarms JV Reaches Q2 Sales of $32 Million, 78% EBITDA Margin, $0.65/Gram All-in Production Cost, and Third Consecutive Quarter of Profitability
VICTORIA, British Columbia, Aug. 13, 2019 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has provided preliminary, unaudited financial results for the second quarter of 2019 for its BC-based 50%-owned joint venture, Pure Sunfarms (PSF). The Company will report its complete financial results for the second quarter ended June 30, 2019, after …
